• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Erythorbic Acid (Molecular Formula:C₆H₈O₆)
Sodium Erythorbate(Molecular Formula:C₆H₇NaO₆·H₂O)
water filter
WATER FILTER FOR WATER PURIFIER
DUST BAG
Small dust filter

Nigeria is working on COVID-19 vaccine, president says

FirstWordPharmaJanuary 07, 2022

Tag: Nigeria , COVID-19 , Vaccine

Nigeria's president says the country is working to develop a COVID-19 vaccine as it battles growing cases of the virus, as reported in the Financial Post.

The West African country has been exploring options to acquire or purchase vaccines through the COVAX facility to enable it to inoculate at least 70% of its population.

It received vaccine donations some of which had a shelf life that left only weeks to administer the shots. Nigeria destroyed more than one million expired vaccines last month.

"We are working very hard with the ministry of health to develop vaccines," said President Muhammadu Buhari, adding "we shouldn't make noise about it until we succeed."

Previous:Imvaq Therapeutics Signs a Service and Commercial Product License to Use ProBioGen’s AGE1.CR® Vaccine Manufacturing Platform

Next:China rushes to develop an mRNA vaccine as doubts grow over local jabs

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

Nigeria is working on COVID-19 vaccine, president says - PharmaSources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

Real Time Multiplex RT-PCR Kit (for COVID-19)

Real Time Multiplex RT-PCR Kit (for COVID-19)
High-standard Influenza Vaccine (Split virion), inactivated

High-standard Influenza Vaccine (Split virion), inactivated
Recombinant Hepatitis B Vaccine(Saccharomyces Cerevisiae)

Recombinant Hepatitis B Vaccine(Saccharomyces Cerevisiae)
Human Vaccine

Human Vaccine
Animal Vaccine Filling Line

Animal Vaccine Filling Line
Hualan-Inactivated Influenza Vaccine(Split Virion) manufactured by Hualan Bio

Hualan-Inactivated Influenza Vaccine(Split Virion) manufactured by Hualan Bio
Hualan good immunogenicity performance Influenza Vaccine

Hualan good immunogenicity performance Influenza Vaccine
Hepatitis A (Live) Vaccine, Freeze-Dried

Hepatitis A (Live) Vaccine, Freeze-Dried
Flu Vaccine by Hualan Bio

Flu Vaccine by Hualan Bio
Influenza Vaccine(Split Virion),Inactivated manufactured by Hualan Bio

Influenza Vaccine(Split Virion),Inactivated manufactured by Hualan Bio

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service